StockDriftsStockDriftsTop 9 M28 Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 56.53% | 4.59M | $26.7M | +0.00%(+0) | $3.69(+46.43%) | 2026-06-30 | |
| IVVD | INVIVYD INC | 17.11% | 9.25M | $8.1M | +0.00%(+0) | $16.62(-95.66%) | 2026-06-30 | |
| TGTX | TG THERAPEUTICS INC | 10.29% | 88.4K | $4.9M | +0.00%(+0) | $15.89(+206.68%) | 2026-06-30 | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 6.37% | 36.9K | $3.0M | +0.00%(+0) | $36.81(+135.40%) | 2026-06-30 | |
| GUTS | FRACTYL HEALTH INC | 3.13% | 1.86M | $1.5M | +0.00%(+0) | $7.40(-90.81%) | 2026-06-30 | |
| PRQR | PROQR THRAPEUTICS N V | 2.37% | 599.8K | $1.1M | +0.00%(+0) | $3.39(-43.43%) | 2026-06-30 | |
| SLN | SILENCE THERAPEUTICS PLC | 2.36% | 101.2K | $1.1M | +0.00%(+0) | $8.60(+59.46%) | 2026-06-30 | |
| RCKT | ROCKET PHARMACEUTICALS INC | 1.53% | 210.9K | $721K | +0.00%(+0) | $23.24(-85.07%) | 2026-06-30 | |
| CRIS | CURIS INC | 0.32% | 284.9K | $149K | +0.00%(+0) | $1285.06(-99.86%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (18 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | +1.85% | +5.67% | — | — | -51.33% |
| Top 20 Holdings Unweighted | +13.81% | +47.43% | — | — | -4.29% |
M28 Capital Management LP reports $47.16M in US-listed equity holdings across 9 positions in its most recent 13F filing. Its largest disclosed positions are WVE (56.5%), IVVD (17.1%) and TGTX (10.3%). The top 20 holdings account for 100.01% of reported assets. Its disclosed equity book has returned +5.67% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Sign up free to track M28 Capital Management LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from M28 Capital Management LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1807489). View M28 Capital Management LP’s 13F filings on SEC